MedTrace Logo

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease

NCT00291421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2360

Last updated 2013-04-16

No results posted yet for this study

Summary

The purpose of this study is to collect and compare information regarding the treatment and outcome of patients diagnosed with Alzheimer's disease who are receiving either drug or nondrug treatment. Information will be collected from patients and their primary caregivers.

Conditions

  • Alzheimer Disease
  • Dementia
  • Nervous System Diseases
  • Mental Disorders
  • Brain Diseases

Sponsors & Collaborators

  • Janssen Pharmaceutica N.V., Belgium

    lead INDUSTRY

Principal Investigators

  • Janssen Pharmaceutica N.V. Clinical Trial · Janssen Pharmaceutica N.V.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Completion
2006-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00291421 on ClinicalTrials.gov